Generics

Innovative 1

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-075 manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Canada

Clear all

1 products found

pp-075

Solution for injection/infusion

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Canada
Comments
Indication: Pulmonary fibrosis, addressing chronic progressive scarring of lung tissue associated with dysregulated innate immune signaling. Clinical stage: Phase 2 Modality: Monoclonal antibody Mechanism / Target: Anti-TLR4 monoclonal antibody designed to inhibit innate immune activation pathways implicated in fibrotic remodeling, excessive extracellular matrix deposition, and inflammation-driven decline in pulmonary function. Route / form: Systemic administration (formulation not publicly specified). Differentiation: Aims to address upstream innate immune drivers of fibrosis rather than downstream inflammation or symptom pathways; represents a novel biologic approach that may complement or outperform current antifibrotic agents with limited efficacy.
Manufacturer #38616

A clinical-stage biopharmaceutical company developing innovative therapies for inflammatory and immune-related diseases, with a focus on dermatology and serious respiratory conditions. It advances host-directed biologics and small molecule programs through global clinical studies and strategic partnerships. The organization targets unmet needs with novel mechanisms beyond standard treatments.
 

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.